| |
| Common & Systematic Cross References to Selected Peptides |
| |
| |
|
ACTH 4-10 |
Met-Glu-His-Phe-Arg-Trp-Gly |
|
ACTH 34-39 |
Ala-Phe-Pro-Leu-Glu-Phe |
|
ADJUVANT PEPTIDE |
N-Acetyl-Muramyl-Ala-d-Ilegln |
|
ANTIOTENSIN I, Ile5 |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu |
|
ANTIOTENSIN I CONVERTING ENZYME INHIBITOR |
Pyrgly-Leu-Pro-Pro-Arg-Pro-Lys-Ile-Pro-Pro |
|
ANTIOTENSIN CONVERTING ENZYME SUBSTRATE |
Hip-His-Leu |
|
ANTIOTENSIN II |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe |
|
ANTIOTENSIN II INHIBITOR |
Sar-Arg-Val-Tyr-Ile-His-Pro-Gly |
|
ANTIOTENSIN II INHIBITOR |
Sar-Arg-Val-Tyr-Ile-His-Pro-Leu |
|
ANTIOTENSIN III HUMAN |
Arg-Val-Tyr-Ile-His-Pro-Phe |
|
ANTIOTENSIN III HUMAN |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe |
|
ANTIOTENSIN III INHIBITOR |
Arg-Val-Tyr-Ile-His-Pro-Ile |
|
ANTIOTENSIN CONVERTING ENZYME INHIBITOR |
Arg-Gly-Leu-Pro-Pro-Gly-Pro-Ile-Pro-Pro |
|
ANTIPAIN |
((S)-1-Carboxy-2-Phenethyl)-Carbamoyl-Arg-Val-Arg |
|
BOC-CCK 26-33 |
N-a-t-BOC-Tyr-Met-Gly-Trp-Met-Asp-Met NH2 |
|
BOC-CCK 28-33 |
N-a-t-BOC-Met-Gly-Trp-Met-Asp-Phe NH2 |
|
BOC-CCK 29-33 |
N-a-t-BOC-Gly-Trp-Met-Asp-Phe NH2 |
|
BOC-CCK 30-33 |
N-a-t-BOC-Trp-Met-Asp-Phe NH2 |
|
BOC LEU ENKEPHALIN |
N-a-t-BOC-Tyr-Gly-Gly-Phe-Leu |
|
BOC MET ENKEPHALIN |
N-a-t-BOC-Tyr-Gly-Gly-Phe-Met |
|
BOMBESIN 9-14 |
Ala-Val-Gly-His-Leu-Met NH2 |
|
BOMBESIN 11-14 |
Gly-His-Leu-Met NH2 |
|
BOMBESIN 10-14 |
Val-Gly-His-Leu-Met NH2 |
|
BOMBESIN 12-14 |
His-Leu-Met NH2 |
|
BOMBESIN 13-14 |
Leu-Met NH2 |
|
BRADYKININ |
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg triacetate |
|
BRAIN PEPTIDE |
Thr-Val-Leu |
|
BRAIN PEPTIDE |
Tyr-D-Ala-Gly-Phe-Met (0)-ol |
|
BRAIN PEPTIDE |
Tyr-D-Ala-Gly-Phe-Met-ol |
|
BRAIN PEPTIDE |
Tyr-Ala-Arg |
|
BRAIN PEPTIDE |
Tyr-Gly-Gly-Phe-Met |
|
BRAIN PEPTIDE |
Tyr-D-Met-Gly-Phe-Pro NH2 |
|
BRAIN PEPTIDE |
Tyr-Phe-Arg |
|
BRAIN PEPTIDE |
Tyr-Pro-Phe-Arg |
|
CCK-PZ HEPTAPEPTIDE |
Tyr-Met-Gly-Trp-Met-Asp-Phe NH2 |
|
CCK-PZ HEXAPEPTIDE |
Met-Gly-Trp-Met-Asp-Phe NH2 |
|
CCK-PZ PENTAPEPTIDE |
Gly-Trp-Met-Asp-Phe NH2 |
|
CCK-PZ C TERMINAL |
Met-Asp-Phe NH2 |
|
CCK-PZ CARBOXY TERMINAL ENDS |
Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe NH2 |
|
CAERULEIN SEQUENCE |
Asp-Tyr-Thr-Gly-Trp-Met-Asp-Phe NH2 |
|
CHROMOPHORE COLLAGENASE SUBSTRATE |
4-Phenylazobenzyloxycarbonyl-Pro-Leu- Gly-Pro-D-Arg |
|
CHROMOPHORE COLLAGENASE SUBSTRATE |
4-Phenylazobenzyloxycarb0onyl-Pro-Leu |
|
ELASTASE SUBSTRATE |
N-Acetyl-Ala-Ala-Ala-Ala-methylester |
|
ELASTASE SUBSTRATE |
Ala-Ala-Ala-methylester acetate |
|
ENCEPHALITOGENIC NONAPEPTIDE |
H2N-Phe-Ser-Trp-Gly-Ala-Glu-Gly-Gln-Arg |
|
EOSINOPHILATIC TETRAPEPTIDE |
Val-Gly-Ser-Glu |
|
EOSINOPHILATIC TETRAPEPTIDE |
Ala-Gly-Ser-Glu |
|
GASTRIN-CAERULEIN SEQUENCE |
Trp-Gly-Phe-NH2 |
|
GASTRIN-CAERULEIN SEQUENCE |
Trp-Met-Gly-Asp-Phe NH2 |
|
GASTRIN-CAERULEIN SEQUENCE |
Trp-Met-Ser-Asp-Phe NH2 |
|
GASTRIN-CAERULEIN SEQUENCE |
Trp-Ser-Phe NH2 |
|
GASTRIN 2-17, HUMAN |
Gly-Pro-Trp-Leu5-Glu-Glu-Glu-Glu-Glu- Ala-Tyr-Gly-Trp-
Leu15-Asp-Phe-NH2 |
|
GASTRIN(15-LEUCINE) HUMAN I |
Pyr-Gly-Pro-Trp-Leu5-Glu-Glu-Glu-Glu- Ala-Tyr-Gly-Trp-
Leu15-Asp-Phe NH2 |
|
GASTRIN(15-METHIONINE) HUMAN I |
Pyr-Gly-Pro-Trp-Leu5-Glu-Glu-Glu-Glu- Glu-Ala-Tyr-Gly-Trp-
Met15-Asp-Phe NH2 |
|
GASTRIN(15-NORLeuCINE) HUMAN I |
Pyr-Gly-Pro-Trp-Leu5-Glu-Glu-Glu-Glu- Glu-Ala-Tyr-Gly-Trp-
Nle15-Asp-Phe NH2 |
|
GlUCAGON 21-29 |
Phe-Val-Gln-Trp-Leu-Met-asn-thr |
|
GlUCAGON HEXAPEPTIDE |
His-Ser-Gln-Gly-thr-Phe |
|
LEUPEPTIN |
Ac-Leu-Leu-Arg.1/2H2SO4 |
|
LEUTINIZING RELEASING FACTOR ANALOGUE |
D-Ala6-LRF |
|
LEUTINIZING RELEASING HORMONE ANALOGUE |
Des-Gly-Leu-LRF ethyl NH2 |
|
LEUTINIZING RELEASING HORMONE ANALOGUE |
Des-Gly10-LRF ethyl NH2 |
|
LEUTINIZING RELEASING HORMONE ANALOGUE |
LRF-p-aminophenyl |
|
LEUTINIZING RELEASING HORMONE ANALOGUE |
D-Lys6-LRF |
|
BETA LIPOPROTEIN 61-91 | beta-Endorphin (Human)
|
|
MODEL PEPTIDE SUBSTRATE | Leu-Trp-Met-Arg-Phe-Ala
|
|
a-MSH STIMULATING HORMONE |
Actyl-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg- Trp-Gly-Lys-Pro-Val NH2y-
Lys-Pro-Val NH2 |
|
MYELIN PROTEIN (HUMAN)114-122 RESIDUES |
Phe-Ser-Trp-Gly-Ala-Glu-Gly-Gln-Arg.COOH |
|
NEUROTENSIN |
pGlu-Leu-Tyr-Glu-asn-Lys-Pro-Arg-Arg- Pro-Tyr-Ile-Leu-OH |
|
PARATHYROID HORMONE (HUMAN)(53-84) |
H-Lys-Lys-Glu-Glu-Asp-Asn-Val-Leu-Val- Glu-Ser-His-Glu-Lys-Ser-Thr-Leu-Val-
Asp-Val-Asp-Ala-Lys-Asp-Ala-Glu-Gly- Leu-Lys-Ala-Lys-Ser-Gln-OH |
|
PEPSTATIN |
Isoval-Val-Val-4-Amino-3-Hydroxy-6- Methylheptanoyl-Ala-4-Amino-3-
Hydroxy-6-Methylheptanoic acid |
|
PENTAGASTRIN |
t-BOC-beta-Ala-Trp-Met-Asp-Phe NH2 |
|
PLASMA KALLEKREIN SUBSTRATE |
CBZ-Phe-Arg-4-methylcoumaryl-7-amide |
|
RENNIN SUBSTRATE |
CBZ-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser- beta naphthylamide |
|
RENNIN SUBSTRATE |
Succinyl-Arg-Pro-Phe-His-Leu-Leu-Tyr- 4-Methylcoumaryl-
7-Amide |
|
RENNIN SUBSTRATE |
H2N-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe- His-Leu-Leu-Val-Tr-Ser-
OH |
|
RNase, C-TERMINAL PENTAPEPTIDE |
Phe-Asp-Ala-Ser-Val |
|
SECRETIN 21-27 |
Arg-Leu-Leu-Gln-Gly-Leu-Leu-Val NH2 |
|
SECRETIN PENTAACETATE |
H-His-Ser-Asp-Gly-Thr-Phe-Phe-Thr-Ser- Glu-Leu-Ser-Arg-Leu-Arg-Asp-Ser-Ala-
Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Gly- Leu-Val NH2 |
|
SILK SEQUENCE |
Ser-Gly-Ala-Gly-Ala-Gly |
|
SOMATOSTATIN |
H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp- Lys-Thr-Phe-Thr-Ser-Cys-OH |
|
SUBSTANCE P |
H2N-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Gly-Leu-Met |
|
TERAGASTRIN |
Trp-Met-Asp-Phe NH2 |
|
THYROCALCITONIN 23-32 |
Ser-Gly-Met-Gly-Phe-Gly-Pro-Glu-Thr-Pro NH2 |
|
THYROCALCITONIN 27-32 |
Phe-Gly-Pro-Glu-Thr-Pro NH2 |
|
THYROCALCITONIN 30-32 |
Glu-Thr-Pro NH2 |
|
THYROTROPIC RELEASING HORMONE |
Pyrglu-His-Pro NH2 & others |
|
THYROTROPIC ANALOGUE PEPTIDE |
Pyr-His-Pro NH-n-butyl |
|
THYROTROPIC ANALOGUE PEPTIDE |
Pyrglu-His-Pro CONH2 |
|
TRH ANALOGUE PEPTIDE |
Pyr-His-Pro NH-C2H5 |
|
TRH ANALOGUE PEPTIDE |
Pyr-His-Pro NH-CH3 |
|
TRH ANALOGUE PEPTIDE |
Pyr-His-Pro NH-n-propyl |
|
TUFSTIN |
Thr-Lys-Pro-Arg |
|
(TYR1) SOMATOSTATIN |
H-Tyr-Gly-Cys-Lys-Asn-Phe-Phe-Trp- Lys-Thr-Phe-Thr-Ser-Cys-OH |
|
(TYR8) SUBSTANCE P |
H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr- Gly-Leu-Met NH2 |
|
VIP (VASOACTIVE INTESTINAL PEPTIDE) |
NH2-His-Ser-Asp-Ala-Val-Phe-Thr-Asp- Asn-Tyr-Thr-Arg-Leu-Arg-
Lys-Gln-Met- Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile- Leu-Asn-NH2
|
|
UROKINASE SUBSTANCE |
CBZ-Gly-Gly-Arg-4-methylcoumaryl-7-amide |
| |